​

Funding Round

Venture Round - RareCyte

Venture Round - RareCyte

Investment Firm

Overview

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

Announced Date

Jun 27, 2024

Closed on Date

Jun 27, 2024

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

Arboretum Ventures

Arboretum Ventures

Arboretum Ventures is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

F-Prime Capital

F-Prime Capital

F-Prime Capital is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

7

Investor Name
Participant InvestorAgilent Technologies
Participant Investor5AM Ventures
Participant InvestorHealthQuest Capital
Participant InvestorF-Prime Capital
Participant InvestorArboretum Ventures

Round Details and Background

RareCyte raised $20000000 on 2024-06-27 in Venture Round

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 03, 2022
Grant - RareCyte
1-undefined
Jun 27, 2024
Venture Round - RareCyte
9-20.0M
Aug 29, 2017
Venture Round - RareCyte
3-30.0M
Aug 21, 2012
Venture Round - RareCyte
1-undefined

Recent Activity

There is no recent news or activity for this profile.